Musculax



Indications and Reactions:

Role Indications Reactions
Primary
Maintenance Of Anaesthesia 25.0%
Muscle Relaxant Therapy 16.7%
Pain 16.7%
Acidosis 8.3%
Anaesthetic Premedication 8.3%
Diuretic Therapy 8.3%
Infection Prophylaxis 8.3%
Swelling 8.3%
Procedural Complication 100.0%
Secondary
Induction Of Anaesthesia 18.9%
Maintenance Of Anaesthesia 9.1%
Analgesia 8.0%
Anaesthetic Premedication 7.4%
Anaesthesia 5.7%
Premedication 5.7%
Surgery 5.7%
Ulcer 5.1%
Hypertension 4.6%
Induction And Maintenance Of Anaesthesia 4.6%
General Anaesthesia 4.0%
Hypotonia 4.0%
Infection Prophylaxis 2.9%
Anaesthesia Procedure 2.3%
Analgesic Therapy 2.3%
Local Anaesthesia 2.3%
Status Asthmaticus 2.3%
Antibiotic Level 1.7%
Prophylaxis 1.7%
Resuscitation 1.7%
Tracheal Oedema 15.4%
Anaphylactic Shock 11.5%
Cardiac Output Decreased 11.5%
Inappropriate Antidiuretic Hormone Secretion 11.5%
Obstructive Airways Disorder 7.7%
Post Procedural Complication 7.7%
Shock 7.7%
Cardiac Arrest 3.8%
Laryngeal Oedema 3.8%
Procedural Complication 3.8%
Quadriplegia 3.8%
Tongue Oedema 3.8%
Ventricular Hypokinesia 3.8%
Vomiting 3.8%
Concomitant
Fluid Replacement 11.9%
Sedation 11.6%
Prophylaxis 7.9%
Infection 7.0%
Induction Of Anaesthesia 6.1%
Ureteral Stent Insertion 5.1%
Ureteral Stent Removal 5.1%
Maintenance Of Anaesthesia 4.7%
Pyrexia 4.4%
Diuretic Therapy 4.0%
Infection Prophylaxis 3.9%
Analgesic Therapy 3.6%
Hypertension 3.5%
Hypotonia 3.4%
Anaesthesia 3.3%
General Anaesthesia 3.2%
Insomnia 3.1%
Electrolyte Substitution Therapy 3.0%
Blood Pressure Management 2.5%
Induction And Maintenance Of Anaesthesia 2.4%
Rhabdomyolysis 11.5%
Delayed Recovery From Anaesthesia 10.3%
Respiratory Failure 10.3%
Shock 9.0%
Hepatic Function Abnormal 7.7%
Electrocardiogram Qt Prolonged 5.1%
Pulmonary Embolism 5.1%
Ventricular Tachycardia 5.1%
Disseminated Intravascular Coagulation 3.8%
Drug Ineffective 3.8%
Strongyloidiasis 3.8%
Upper Airway Obstruction 3.8%
Cholecystitis Acute 2.6%
Eyelid Oedema 2.6%
Hepatitis Fulminant 2.6%
Hypotension 2.6%
Inappropriate Antidiuretic Hormone Secretion 2.6%
Pancytopenia 2.6%
Post Procedural Complication 2.6%
Renal Impairment 2.6%
Interacting
Biliary Tract Infection 50.0%
Muscle Relaxant Therapy 50.0%
Drug Effect Prolonged 50.0%
Drug Interaction 50.0%